Clinical Trials Logo

Osteoarthritis, Knee clinical trials

View clinical trials related to Osteoarthritis, Knee.

Filter by:

NCT ID: NCT00519922 Completed - Knee Osteoarthritis Clinical Trials

A Study of the Effectiveness of Different Types of Exercise for People With Knee Osteoarthritis

KBA Exercise
Start date: January 2008
Phase: N/A
Study type: Interventional

This pilot study will test the testing and exercise training protocols for a larger study that is in the desing phase and may be modified based on the findings of this study. Two exercise groups will be compared; one is a stadard treatment group using leg strength exercises that are commonly employed in therapy clinics. The other group will do balance and agility type exercises, but no specific strength exercises. These "KBA" exercises are increasingly common in therapy clinics, but very little research has been conducted on their effectiveness in treating knee osteoarthritis symptoms. Participants in this study will complete three short paper and pencil tests at the beginning and end of the study (8 weeks of exercise) as well as a leg strength test, a leg endurance test, two short walking tests, and a stair climb/descend test. One of the paper and pencil tests will be taken every two weeks in an effort to see how quickly changes to symptoms might occur. The exercise programs will be conducted 3 afternoons per week (Mon-Wed-Fri) and will be lead by an ACSM certified instructor.

NCT ID: NCT00504127 Completed - Osteoarthritis Clinical Trials

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

Start date: April 2007
Phase: Phase 3
Study type: Interventional

To study of efficacy and safety of Naproxcinod vs. Naproxen and Placebo in the indication of signs and symptoms of osteoarthritis

NCT ID: NCT00504114 Completed - Clinical trials for Osteoarthritis, Knee

MR Imaging of Knee Osteoarthritis and Acute Knee Injuries

Start date: August 2006
Phase: N/A
Study type: Observational

The purpose of this study is to use better magnetic resonance imaging (MRI) techniques to examine the knee and the bony and soft tissue changes so as to better predict the progression of osteoarthritis and acute knee injuries.

NCT ID: NCT00503828 Completed - Knee Osteoarthritis Clinical Trials

Derris Scandens Benth Extract VS Naproxen in Knee OA

Start date: July 2007
Phase: Phase 3
Study type: Interventional

Derris Scandens Benth (family : Leguminosae) is a woody vine growing throughout Southeast Asia, including Thailand. The stem of D.Scandens has been widely use in Thai traditional medicine, foe example of myalgia. Previous study shown that D.Scandens Benth extract has the anti-inflammatory activity. Although NSAIDs are efficaciously in the treatment of osteoarthritis,but the GI side effect is still concerned. In this study we aim to investigate the efficacy and safety of D. Scandens Benth extract compared with Naproxen for therapy of patients with knee osteoarthritis.

NCT ID: NCT00488267 Completed - Osteoarthritis Clinical Trials

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

Start date: June 2007
Phase: Phase 3
Study type: Interventional

ThermoProfen is a transdermal ketoprofen patch that is integrated with a long-lasting CHADD (Controlled Heat-Assisted Drug Delivery) unit for the treatment of chronic pain associated with osteoarthritis. This study will evaluate ThermoProfen for the treatment of mild to moderate pain associated with osteoarthritis of the knee in adults.

NCT ID: NCT00487370 Completed - Clinical trials for Osteoarthritis, Knee

Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis

Start date: March 1997
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether implanting gold beads extraarticularly in five acupuncture-points around a knee improves pain, stiffness and function in patients with knee osteoarthritis.

NCT ID: NCT00486811 Completed - Pain Clinical Trials

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Start date: June 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether tapentadol (CG5503) prolonged-release (PR) tablets at doses of 100-250 mg twice daily provide a better pain relief in patients with moderate to severe chronic pain due to osteoarthritis of the knee than a placebo (a medication without active substance). In addition the tolerability of CG5503 PR will be assessed. One third of the patients will receive CG5503 and one third will receive placebo. For further comparison one third of the patients will receive oxycodone controlled release (CR) at doses of 20-50 mg twice daily which is an active approved pain medication. Please note that tapentadol ER (Extended Release) and tapentadol PR (Prolonged Release) are identical and used interchangeably. This is due to United States of America and European naming conventions.

NCT ID: NCT00486434 Completed - Osteoarthritis Clinical Trials

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

Start date: May 2007
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoarthritis of the knee.

NCT ID: NCT00484120 Completed - Clinical trials for Osteoarthritis of the Knee

Proof-of Concept Study of Topical 3%-Diclofenac-Nano-Emulsion Cream for Knee OA Pain

Start date: June 2007
Phase: Phase 2
Study type: Interventional

This study valuates the safety and efficacy of treatment with 3% Diclofenac Nano-Emulsion Cream versus Placebo in subjects with osteoarthritis of the knee.

NCT ID: NCT00476034 Completed - Osteoarthritis Clinical Trials

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Start date: December 2003
Phase: Phase 3
Study type: Interventional

This 39-week, active controlled, study is designed to assess long-term efficacy, safety and tolerability of lumiracoxib 100mg od in patients with osteoarthritis (OA) of the knee who participated in the 13-week core CCOX189A2361 study.